EMA — authorised 23 July 2012
- Marketing authorisation holder: EISAI GMBH
- Status: approved
EMA authorised Fycompa on 23 July 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 23 July 2012.
EISAI GMBH holds the EU marketing authorisation.